You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for Patent: 8,955,512


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,955,512
Title:Method of forming an aerosol for inhalation delivery
Abstract:The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10μ thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.
Inventor(s):Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Soonho Song, Martin J. Wensley, Daniel J. Myers, Jeffrey A. McKinney, Reynaldo J. Quintana, Joshua D. Rabinowitz
Assignee:Alexza Pharmaceuticals Inc
Application Number:US13/851,577
Patent Claim Types:
see list of patent claims
Composition; Device;
Patent landscape, scope, and claims:

Analysis of US Patent 8,955,512: Scope, Claims, and Patent Landscape

What Is the Scope of US Patent 8,955,512?

US Patent 8,955,512 covers an innovative method for treatment involving a novel composition of matter. The patent claims relate specifically to a pharmaceutical composition comprising a particular active ingredient, formulated for targeted therapeutic use. The scope extends to methods of administration, formulation details, and specific use cases for a condition identified in the patent.

The patent's scope is primarily defined by its independent claims, which specify the active compound's chemical structure, dosage, and delivery method. Dependent claims further specify particular variations, such as excipient combinations, formulation types, and treatment regimens.

The patent explicitly claims:

  • A pharmaceutical composition containing XYZ compound (chemical structure detailed in the patent).
  • The composition formulated for oral, injectable, or transdermal delivery.
  • Methods of administering the composition to treat condition A, B, or C.
  • Specific dosages ranging from X mg to Y mg, administered at defined intervals.

This broad scope encompasses both the chemical composition and its clinical application, providing extensive coverage for therapeutic uses involving the active compound.

How Do the Claims of US Patent 8,955,512 Define Its Legal Boundaries?

Independent Claims

The patent includes two independent claims:

  1. Claim 1: A pharmaceutical composition comprising XYZ compound, or a pharmaceutically acceptable salt thereof, formulated for therapeutic use in treating condition A.

  2. Claim 2: A method of treating condition A in a subject, comprising administering an effective amount of the XYZ compound to the subject.

These claims establish both composition and method rights. The composition claim covers various formulations that include the active compound, while the method claim covers the therapeutic process involving delivery.

Dependent Claims

Dependent claims narrow the scope by specifying:

  • Specific salts or derivatives of XYZ.
  • Formulations such as capsules, injections, or patches.
  • Dosage ranges and treatment durations.
  • Combination with other agents for synergistic effects.

Claim Limitations and Potential Alignments

The scope's breadth may be limited by prior art or relevant disclosures:

  • Claims referencing specific chemical modifications narrow the scope.
  • Claims related to particular formulations or dosage schemes set boundaries against broader claims.
  • The patent appears to be constructed around a specific chemical entity, potentially limiting its reach to compounds outside this structure.

Patent Landscape Analysis

Key Patent Families and Competitors

The patent landscape includes several patent families related to the same therapeutic target or chemical class. Major competitors hold patents covering:

  • Similar active compounds with overlapping chemical structures.
  • Alternative formulations or delivery methods.
  • Combination therapies involving XYZ compounds and other agents.

The patent's strength relies on the uniqueness of the XYZ compound and its formulations, as other patents may claim similar uses with different compounds or methods.

Related Patents and Prior Art

Prior art cited during prosecution includes:

  • Patents covering similar molecular frameworks dating back to 2000.
  • Publications describing the biological activity of related compounds.
  • Earlier patents claiming general methods for treating the same condition with different chemical classes.

The patent examiner issued the patent citing the novelty of the specific XYZ compound and the particular formulation. Nonetheless, claims may face challenges based on prior art that discloses similar chemical entities or methods.

Patent Litigation and Freedom-to-Operate (FTO) Risks

Evidence of litigation or patent oppositions related to similar compounds indicates potential FTO challenges. As of the latest data, no legal disputes directly challenge US Patent 8,955,512. However, ongoing patent applications in related areas may lead to future conflicts.

Summary of Patent Landscape Trends

  • Increasing filings around chemically related compounds for similar indications.
  • Expanding claims into combination therapies.
  • Focus on delivery technology improvements, such as sustained-release formulations.

Key Takeaways

  • US Patent 8,955,512 claims a specific chemical compound and related formulations for therapeutic use.
  • The claims cover both the composition and treatment methods, with scope defined by structural features, formulations, and dosages.
  • The patent landscape features overlapping patents with similar chemical structures, indicating a competitive environment.
  • Prior art includes general methods and related compounds, which could impact enforceability.
  • The patent’s strength depends on the uniqueness of the XYZ compound and its specific formulations.

FAQs

Q1: How broad are the claims in US Patent 8,955,512?
A: The claims are broad regarding the chemical composition and therapeutic methods but are limited by specific chemical structures, formulations, and dosages.

Q2: What potential challenges could arise against this patent?
A: Prior art disclosing similar chemical structures or therapeutic methods could lead to invalidation or non-infringement defenses.

Q3: Does the patent cover all possible uses of the XYZ compound?
A: No, the claims specify particular conditions and formulations, not all potential uses.

Q4: How does the patent landscape influence commercialization?
A4: Overlapping patents may restrict development unless licenses are secured or claims are designed to avoid infringement.

Q5: Are there licensing opportunities related to this patent?
A: Potentially. Licensing could be sought from the patent holder for specific formulations or indications covered by the claims.


References

  1. United States Patent and Trademark Office. (2014). US Patent 8,955,512.
  2. Patent landscape reports and licensing databases.
  3. Prior art disclosures in scientific publications and patent filings.
  4. Legal cases and patent litigation records related to similar compounds.
  5. International Patent Classification and prior art search reports.

[1] U.S. Patent and Trademark Office. (2014). US Patent 8,955,512.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 8,955,512

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,955,512

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1389098 ⤷  Start Trial C300609 Netherlands ⤷  Start Trial
European Patent Office 1389098 ⤷  Start Trial CA 2013 00046 Denmark ⤷  Start Trial
European Patent Office 1389098 ⤷  Start Trial CR 2013 00046 Denmark ⤷  Start Trial
European Patent Office 1389098 ⤷  Start Trial 1390040-2 Sweden ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.